Published in:
01-06-2017 | Meeting Report
The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, Canada
Authors:
Maartje C. A. Wouters, Céline M. Laumont, Branson Chen, Seong Jun Han, Kathy Matuszewska, Kyle Potts, Jeanette E. Boudreau, Connie. M. Krawczyk
Published in:
Cancer Immunology, Immunotherapy
|
Issue 6/2017
Login to get access
Excerpt
In June 2016, the Canadian Cancer Immunotherapy Consortium (CCIC), an association dedicated to the scientific advancement of immunotherapy for cancer, partnered with BioCanRx, a Network of Centre of Excellence program focused on biotherapeutics for cancer treatment, to hold the Summit for Cancer Immunotherapy (Summit4CI) in Halifax, Canada. The synergy of these two organizations—both highly active in the field of cancer biotherapy and supported by the Government of Canada—offered a unique opportunity for multidisciplinary discussions and trainee events. Bringing together researchers, trainees, policy makers, patients, physicians, advocates, and industry partners, this unique event presented a holistic perspective on the past, present, and future of cancer immunotherapy, considering how scientific and logistical advances will translate cutting-edge research into novel therapeutics. …
